EN106 emerges as a robust inhibitor of FEM1B, functioning as a covalent ligand reactive to cysteine. Through its cysteine reactivity, EN106 disrupts the recognition process associated with FEM1B's key substrate under reductive stress, namely FNIP1.
Usually ships within 24 hours.